3 studies found for:    parp prostate cancer | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting Studying the Effects of Olaparib Given to Men With Intermediate/High Risk Prostate Cancer Before Radical Prostatectomy
Condition: Prostate Cancer
Interventions: Drug: Olaparib;   Drug: Degarelix
2 Not yet recruiting An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Condition: Prostatic Neoplasms
Intervention: Drug: Niraparib
3 Recruiting Phase I/II Study of the Anti-Programmed Death Ligand-1 Antibody MEDI4736 in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Cancers
Conditions: Lung Cancer;   Breast Cancer;   Ovarian Cancer;   Colorectal Cancer;   Prostate Cancer;   Triple Negative Breast Cancer
Interventions: Drug: Olaparib;   Drug: Cediranib;   Drug: MEDI4736

Indicates status has not been verified in more than two years